Physician profile
Dana S Lycans
NPI 1003251851
$38,953.13
in general payments reported to CMS, 2019-2025
13 companies · $2,065 in 2025
The $2,065 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,449 · 2020: $5,382 · 2021: $7,180 · 2022: $10K · 2023: $2,054 · 2024: $2,751 · 2025: $2,065.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,075 · Food and Beverage: $1,794.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,074.69 |
| Food and Beverage | $1,794.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mid-Atlantic Surgical Systems, LLC | $20,165.17 | 2019-2025 | |
| Arthrex, INC. | $10,324.84 | 2019-2025 | |
| Smith+Nephew, INC. | $6,452.37 | 2019-2024 | Healicoil, Bone Anchors With Arthroscopic Delivery System, Evos |
| Encore Medical, Lp | $791.28 | 2019-2024 | Djo Surgical |
| Linvatec Corporation | $413.19 | 2019 | |
| Zynex Medical, INC. | $196.35 | 2025 | Nexwave |
| Stryker Corporation | $179.52 | 2023-2025 | Pangea, Inspace |
| Vericel Corporation | $120.82 | 2023 | Maci |
| Pacira Therapeutics, INC. | $105.15 | 2019 | |
| My01 INC. | $101.71 | 2024 | My01 Continuous Compartmental Pressure Monitor |
| Si-Bone, INC. | $50.36 | 2023-2024 | |
| Pacira Pharmaceuticals Incorporated | $36.03 | 2023-2025 | Zilretta, Iovera, Exparel |
| Daiichi Sankyo INC. | $16.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Lycans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.